This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Prostate Cancer
  • /
  • Prednisone plus cabazitaxel or mitoxantrone for me...
Journal

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Read time: 1 mins
Published:1st Oct 2010
Author: de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, et al.
Source: The Lancet
Availability: Pay for access, or by subscription
Ref.:Lancet. 2010 Oct 2;376(9747):1147-54.
DOI:10.1016/S0140-6736(10)61389-X.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest